| HOME >> MEDICINE >> TECHNOLOGY |
Table 39: Artificial Pancreas, University of Cambridge, Animas, Pipeline Product, 2011 71
Table 40: Artificial Pancreas System, University of Virginia, Pipeline Product, 2011 71
Table 41: Bionic Pancreas, Imperial College London, Pipeline Product, 2011 71
Table 42: Closed Loop System, Novoculi, Pipeline Product, 2011 72
Table 43: De Montfort – Artificial Pancreas, De Montfort University, Pipeline Product, 2011 72
Table 44: Non-invasive Blood Glucose Monitoring Devices, Pipeline Products – Table I, 2011 74
Table 45: Non-invasive Blood Glucose Monitoring Devices, Pipeline Products – Table II, 2011 75
Table 46: Nanotechnology in Wound Care Management, Nucryst Pharmaceuticals, Product Portfolio, 2011 77
Table 47: Nanotechnology in Wound Care Management, Alltracel Pharmaceuticals, Product Portfolio, 2011 77
Table 48: Nanotechnology in Wound Care Management, Biofisica, 2011 77
Table 49: Nanotechnology in Wound Care Management, Montvale Technologies, 2011 78
1.2 List of Figures
Figure 1: Major Emerging Technology Trends in Medical Devices – An Overview 10
Figure 2: Emerging Technology Trends: Likelihood of Adoption versus Benefit Analysis 11
Figure 3: Drug Eluting Balloons – Impact on the Cardiovascular Devices Market 16
Figure 4: A Comparison of Drug Eluting Balloons and Drug Eluting Stents 17
Figure 5: Drug Eluting Balloons, Global, Revenue ($m), 2010 – 2017 18
Figure 6: Drug Eluting Balloons – Major Players in the Market 19
Figure 7: Transcatheter Heart Valve Technology – Impact Analysis 23
Figure 8: Transcatheter Heart Valves – Opportunity and Risk Assessment Analysis 24
Figure 9: Transcatheter Heart Valves, Global, Revenue ($m), 2010 – 2017 25
Figure 10: Accommodating Intrao
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |